Cargando…

Effects of Ipratropium Bromide Combined with Traditional Chinese Medicine Intervention on the Pulmonary Function and Psychological Status of Patients with Chronic Obstructive Pulmonary Disease

Recently, most scholars have advocated multidisciplinary comprehensive intervention measures for chronic obstructive pulmonary disease (COPD) to improve lung function, relieve symptoms of dyspnea, and improve quality of life. Traditional Chinese medicine (TCM) has rich experience in the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Wen-Yi, Zhao, Hong, Ye, Jing, Sang, Hai-Jin, Zhou, Lin-Shui, Lv, Jia-Ni, Li, Juan-Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928514/ https://www.ncbi.nlm.nih.gov/pubmed/36798728 http://dx.doi.org/10.1155/2023/6483785

Ejemplares similares

Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease
por: Li, Xuan, et al.
Publicado: (2017)

The Effect of Ipratropium Bromide with Violet Flower Extract, Ipratropium Bromide with Budesonide, and Ipratropium Bromide Alone on the Cuff-Leak of the Endotracheal Tube in Intubated ICU Patients
por: Hashemi, Seyed Taghi, et al.
Publicado: (2023)

Bromangiomas-ipratropium bromide–associated angiomas
por: Samlaska, Curt, et al.
Publicado: (2019)

Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease
por: Panos, Ralph J
Publicado: (2013)

Bioequivalence study of ipratropium bromide inhalation aerosol using PBPK modelling
por: Zhang, Jisheng, et al.
Publicado: (2023)

Rare causes of anisocoria: Ipratropium bromide and Angel’s trumpet
por: Ekici, Arzu, et al.
Publicado: (2021)

Use of inhaled ipratropium bromide to improve exercise-induced laryngeal obstruction cannot be recommended
por: Muralitharan, Praveen, et al.
Publicado: (2023)

Unilateral mydriasis secondary to ipratropium bromide in a critically ill patient
por: Santana-Cabrera, Luciano, et al.
Publicado: (2012)

Transient anisocoria in a patient treated with nebulized ipratropium bromide
por: Pejic, Renato, et al.
Publicado: (2017)

Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein
por: Dong, Yuan, et al.
Publicado: (2022)

Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis
por: Xu, Hongzhen, et al.
Publicado: (2021)

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain
por: Rutten-van Mölken, Maureen P. M. H., et al.
Publicado: (2007)

Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting
por: Gauhar, Umair, et al.
Publicado: (2009)

Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
por: Haney, Sarah, et al.
Publicado: (2007)

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study
por: Ferguson, Gary T, et al.
Publicado: (2013)

Ipratropium bromide is more effective than Salmeterol — Fluticason combination on O(2) saturation patients with COPD
por: Rezaie, Nader, et al.
Publicado: (2013)

Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD
por: Bhattacharya, Amal, et al.
Publicado: (2016)

Compatible Stability and Aerosol Characteristics of Atrovent(®) (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine
por: Chen, Yiting, et al.
Publicado: (2020)

Nebulized Ipratropium bromide protects against tracheal and bronchial secretion during bronchoscopy: A randomized controlled trial
por: Wang, Faping, et al.
Publicado: (2019)

Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
por: Naveed, Hina, et al.
Publicado: (2023)

Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD
por: De Backer, LA, et al.
Publicado: (2011)

Unilateral pupillary mydriasis from nebulized ipratropium bromide: A false sign of brain herniation in the intensive care unit
por: Chaudhry, Priyanka, et al.
Publicado: (2014)

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
por: Donohue, James F., et al.
Publicado: (2016)

Effects of ipratropium bromide on the occurrence of postoperative respiratory complications in craniectomy patients with COPD: A nationwide multicenter retrospective study
por: Du, Zhuoying, et al.
Publicado: (2020)

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease
por: Sims, Michael W, et al.
Publicado: (2011)

Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
por: Zhong, Jun, et al.
Publicado: (2014)

Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
por: Jones, Paul W
Publicado: (2015)

Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma
por: Alvarado-Gonzalez, Alcibey, et al.
Publicado: (2015)

The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China
por: Huang, Kewu, et al.
Publicado: (2019)

Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered‐Dose Inhaler
por: MacGregor, TR, et al.
Publicado: (2016)

Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine
por: Tsou, Yung-An, et al.
Publicado: (2014)

Ipratropium Bromide/Salbutamol-Induced Acute Urinary Retention as a Result of Medication Error: A Case Report and Review of Cases in the Literature
por: Kubas, Mohammed Abdullah, et al.
Publicado: (2023)

The Acute Effects of the Use of Salbutamol and Ipratropium on the Heart Rates of Patients With Obstructive Airway Disease
por: Akhtar, Ayesha, et al.
Publicado: (2023)

Aerosol Characteristics and Physico-Chemical Compatibility of Combivent(®) (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine
por: Zhang, Rui, et al.
Publicado: (2020)

Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease
por: Tanaka, Ken-Ichiro, et al.
Publicado: (2014)

Current Status of Standardization of Traditional Chinese Medicine in China
por: Wang, Juan, et al.
Publicado: (2016)

Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease
por: Yang, Yang, et al.
Publicado: (2020)

Expert consensus and operational guidelines on exercise rehabilitation of chronic obstructive pulmonary disease with integrating traditional Chinese medicine and Western medicine
por: Chen, Xuan, et al.
Publicado: (2021)

Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review
por: Spyratos, Dionisios, et al.
Publicado: (2015)

Tiotropium Bromide Attenuates Mucus Hypersecretion in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Yu, Suyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74mmuq3muhshn57anba2oo09jf